Mayo is one of 21 centers participating in a clinical trial examining the effects of glucose control in diabetes complications. Pts are admitted to the GCRC for improvement of intensive insulin therapy. Also involves outpatient evaluations.
Showing the most recent 10 out of 1267 publications